ACID PEPTIC DISEASE IN LONDON -- ETHNIC DIFFERENCES AND TIME TRENDS
- Dyspeptic Symptoms and Endoscopic Findings in the Community: The Loiano—Monghidoro Study. Zagari, Rocco Maurizio; Law, Graham Richard; Fuccio, Lorenzo; Pozzato, Paolo; Forman, David; Bazzoli, Franco // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p565
OBJECTIVES:We aimed to evaluate the prevalence of endoscopic findings and their association with dyspeptic symptoms in the community.METHODS:A total of 1,533 inhabitants of two villages were invited to participate in a cross-sectional survey, and 1,033 were recruited. Participants underwent a...
- Bleeding peptic ulcers. Bown, Stephen // BMJ: British Medical Journal (International Edition);6/15/91, Vol. 302 Issue 6790, p1417
Examines the hospital care for bleeding peptic ulcers. Assessment of the exact bleeding point at emergency endoscopy; Statistics of patients recovering from peptic ulcer; Benefits of endoscopy.
- Combination Treatment for Peptic Ulcers at High Risk for Recurrent Bleeding. Sung, J.J.Y.; Chan, F.K.L.; Lau, J.Y.W.; Yung, M.-Y.; Leung, W.-K.; Wu, J.C.Y.; Ng, E.K.W.; Chung, S.C.S. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, pI12
Focuses on combination treatment for peptic ulcers at high risk for recurrent bleeding. Definition of peptic ulcers; Form of treatment that stop active bleeding and prevent recurrent bleeding; Drugs involved in endoscopic treatment of blood vessel.
- The Effect of Endoscopic Therapy in Patients Receiving Omeprazole for Bleeding Ulcers with Nonbleeding Visible Vessels or Adherent Clots. Sung, Joseph J.Y.; Chan, Francis K.L.; Lau, James Y.W.; Man-Yee Yung; Wai-Keung Leung; Wu, Justin C.Y.; Ng, Enders K.W.; Sydney Chung, S.C. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, p237
Focuses on the effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Effect of endoscopic treatment on bleeding from peptic ulcers; Different approaches of treating bleeding from a peptic ulcer patients; Method of...
- CLINICAL EFFECTIVENESS OF IV OMEPRAZOLE IN ENDOSCOPICALLY TREATED PEPTIC ULCERS. Donnellan, C.F.; Clements, D.G.; Watt, A.L.; Healey, C.J. // Gut;Apr2003 Supplement 1, Vol. 52, pA114
Introduction: Airedale Hospital is a DGH serving a population of 200 000 in North and West Yorkshire. Publication of RCT data has recently demonstrated significant benefits of a 72 hour IV omeprazole infusion, for patients with peptic ulcers who undergo endoscopic haemostasis. This therapy was...
- Failure of increased use of endoscopy to influence complication rate in peptic ulcer disease. Holdstock, G.; Colley, S. // British Medical Journal (Clinical Research Edition);8/6/1983, Vol. 287 Issue 6389, p393
Focuses on the failure of increased use of endoscopy to influence complication rate in peptic ulcer disease. Assessment on the increased use of upper gastrointestinal endoscopy; Importance of accurate diagnosis during hospital admission; Provision of an open access endoscopy service.
- Dual Therapy Versus Monotherapy in the Endoscopic Treatment of High-Risk Bleeding Ulcers: A Meta-Analysis of Controlled Trials. Marmo, Riccardo; Rotondano, Gianluca; Piscopo, Roberto; Bianco, Maria A.; D'Angella, Rosario; Cipolletta, Livio // American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p279
BACKGROUND: There is no definite recommendation on the use of dual endoscopic therapy in patients with severe peptic ulcer bleeding. A systematic review and meta-analysis were performed to determine whether the use of two endoscopic hemostatic procedures improved patient outcomes compared with...
- Esophageal cancer and ulcer medication. E.B. // Medical Update;Dec95, Vol. 19 Issue 6, p1
Focuses on a research funded by the National Cancer Institute on the potential risks posed by ulcer medication for esophageal cancer, published in the August 9, 1995 issue of the `Journal of the American Medical Association.' Evidence suggesting gastroesophageal reflux disease as causative...
- In patients with Barrett oesophagus, H. pylori eradication is safe in those with gastric but not duodenal ulcer. Tsibouris, P.; Hendrickse, M.T.; Joshi, M.; Krommida, A.; Isaacs, P.E.T. // Gut;Sep2002 Supplement 2, Vol. 51, pA66
Although H. pylori(HP) eradication in patients with peptic ulceration is mandatory, its need in patients with concurrent Barrett oesophagus(BO) has never been discussed. Aim of the Study: To define the consequences of HP eradication in BO patients. Patients and Methods: The records of all...